Pragmatic trial of a multidisciplinary lung cancer care model in a community healthcare setting: study design, implementation evaluation, and baseline clinical results

With an estimated incidence of 224,500 new cases and 158,000 deaths, lung cancer accounted for 14% of all cancer cases and 25% of all cancer deaths in the US in 2016. It kills almost as many Americans each year as the second (colorectal), third (pancreas), fourth (breast), and fifth (prostate) most lethal cancers combined. While aggregate 5-year survival rates have improved significantly for breast (90%), colorectal (60%) and prostate (95%) cancers, the overall 5-year survival rate for lung cancer has only increased from 12% in 1975 to 18% in 2016 (1)